1. Activity and safety of metronomic cyclophosphamide in the modern era of metastatic castration-resistant prostate cancer. (19th March 2019) Authors: Caffo, Orazio; Facchini, Gaetano; Biasco, Elisa; Ferraù, Francesco; Morelli, Franco; Donini, Maddalena; Buttigliero, Consuelo; Calvani, Nicola; Guida, Annalisa; Chiuri, Vincenzo Emanuele; Basso, Umberto; Mucciarini, Claudia; Conteduca, Vincenza; Rossetti, Sabrina; Veccia, Antonello; Maines, Franc... Journal: Future oncology Issue: Volume 15:Number 10(2019) Page Start: 1115 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Erratum to 'Clinical progression is associated with poor prognosis whatever the treatment line in metastatic castration-resistant prostate cancer: The CATS international database' [European Journal of Cancer, Volume 125 (January 2020) Pages 153–163]. (September 2020) Authors: Delanoy, Nicolas; Hardy-Bessard, Anne-Claire; Efstathiou, Eleni; Moulec, Sylvestre Le; Basso, Umberto; Birtle, Alison; Thomson, Alastair; Krainer, Michael; Guillot, Aline; Giorgi, Ugo De; Hasbini, Ali; Daugaard, Gedske; Bahl, Amit; Chowdhury, Simon; Caffo, Orazio; Beuzeboc, Philippe; Spaeth, Domi... Journal: European journal of cancer Issue: Volume 137(2020) Page Start: 290 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. INfluenza Vaccine Indication During therapy with Immune checkpoint inhibitors: a transversal challenge. The INVIDIa study. (17th October 2018) Authors: Bersanelli, Melissa; Giannarelli, Diana; Castrignanò, Paola; Fornarini, Giuseppe; Panni, Stefano; Mazzoni, Francesca; Tiseo, Marcello; Rossetti, Sabrina; Gambale, Elisabetta; Rossi, Ernesto; Papa, Anselmo; Cortellini, Alessio; Lolli, Cristian; Ratta, Raffaele; Michiara, Maria; Milella, Michele; L... Journal: Immunotherapy Issue: Volume 10:Number 14(2018) Page Start: 1229 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. TP023/#1560 A phase 3, randomized, double-blind, placebo/paclitaxel-controlled study of batiraxcept in combination with weekly paclitaxel in patients with platinum-resistant recurrent ovarian cancer (GOG-3059/ENGOT OV-66). (4th December 2022) Authors: Fuh, Katherine; Moore, Kathleen; Baert, Thais; Herzog, Thomas; Cibula, David; Liu, Joyce; Eberst, Laurianne; Lewin, Sharon; Secord, Angeles Alvarez; Sehouli, Jalid; Myers, Tashanna; Bamias, Aristotelis; Rimel, BJ; Colombo, Nicoletta; Franke, Amy; Shoop, Dipti; Giorgi, Ugo De; Pikiel, Joanna; Bowe... Journal: International journal of gynecological cancer Issue: Volume 32(2022)Supplement 3 Page Start: A234 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗